Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Problem with the Share Price

<and what happened to the revenues we did receive? >

Mostly spent on the licensing effort and startup companies that did not work out. Might some of those startups worked out if we had the funds to continue holding them? I do not know the answer, but it was clear to me that we were not in a position to hang on to them. And the decisions to let them go and write them off, in all liklihood were good decisions, as painful as they were.

Opty

Share
New Message
Please login to post a reply